HAIR Restoration Robotics Inc

Restoration Robotics™ Launches Next Generation ARTAS® iX Robotic Hair Restoration System

Restoration Robotics™ Launches Next Generation ARTAS® iX Robotic Hair Restoration System

ARTAS® iX Robotic Hair Restoration System With Harvesting And Implantation Functionality Unveiled At The Aesthetic Show™ 2018

SAN JOSE, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ:HAIR), the global leader in robotic hair restoration, today announced the launch of its new ARTAS® iX Robotic Hair Restoration System. The ARTAS iX Robotic Hair Restoration System is the only robotic intelligent solution to offer precise, minimally invasive, repeatable harvesting and implantation functionality in one platform.

The ARTAS iX System is equipped with a 3-camera stereoscopic vision system with 44-micron resolution and a 7-axis robot. The system delivers unmatched procedural analysis, precision, repeatability, and clinical workflow efficiency for hair restoration. ARTAS iX features a compact, motorized, battery-powered, portable and adjustable procedure chair for increased patient comfort and clinical versatility that can be used ergonomically in multiple aesthetic procedures.

Ryan Rhodes, CEO of Restoration Robotics, said, “We believe the introduction of the ARTAS iX system is a major transformative milestone for Restoration Robotics and the hair restoration industry. We believe that the additional features, especially the implantation functionality, significantly enhances our offering to physicians and helps position us to further penetrate the expanding male hair restoration market.”

Robert M. Bernstein, MD, Clinical Professor of Dermatology at the College of Physicians and Surgeons of Columbia University and founder of Bernstein Medical Center for Hair Restoration, a state-of-the-art hair transplant facility in New York, NY commented, “The new ARTAS iX system marks a pivotal development in hair restoration technology. It will enable physicians to deliver outstanding results for their patients while reducing the more labor-intensive aspects of hair restoration procedures. Following a recent demonstration of the system, I believe that it will reduce clinical fatigue and case time through robotic assistance and improved clinical workflow.” 

The ARTAS iX system will be unveiled at The Aesthetic Show™ 2018, where Restoration Robotics is a Premier Sponsor, being held July 5-8 at The Wynn Hotel in Las Vegas, NV. For more information on the ARTAS iX Robotic Hair Restoration System visit .

About Restoration Robotics

Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS™ Robotic Hair Restoration System. The ARTAS System is the first and only physician-assisted system to dissect and assist in the harvesting of follicular units directly from the scalp, create recipient implant sites using proprietary algorithms and now implant the hair follicles into the designated sites. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.

Forward-looking Statements



Statements made in this press release that are not statements of historical fact are forward-looking statements. Forward-looking statements are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are commonly identified by words such as “would,” “may,” “expects,” “believes,” “plans,” “intends,” “projects” and other terms with similar meaning. Investors are cautioned that the forward-looking statements in this press release are based on current beliefs, assumptions and expectations, speak only as of the date of this document and involve risks and uncertainties that could cause actual results to differ materially from current expectations. Such statements are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results and other future events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements.  These statements include, without limitation, the following: our expectations for the global male hair restoration market; our expectations regarding the ability of ARTAS iX to deliver outstanding results and reduce clinical fatigue; whether there is growth in demand for our ARTAS System; the progress of our commercialization, marketing and manufacturing capabilities; the continuing productivity and effectiveness of our commercial infrastructure and salesforce; our expectations regarding the potential market size and the size of the patient populations for ARTAS being accurate; and whether we are effective in the pricing of ARTAS iX. Material factors that could cause actual results to differ materially from current expectations are described in greater detail in our Annual Report on Form 10-K filed on March 5, 2018, as well as any reports that we may file with the SEC in the future. These factors may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. We expressly disclaim any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

Media Contact

Lisa Markle

Director of Marketing

Restoration Robotics, Inc.



 

Investor Contact

The Ruth Group

Lee Roth & Brian Johnston



646-536-7000

EN
05/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Restoration Robotics Inc

 PRESS RELEASE

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial ...

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial Results; Provides Preliminary First Quarter of 2020 Revenue Results and Updates Fiscal Year 2020 Revenue Guidance TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the three months ending March 31, 2020. The Company notes that the financial results provided for the three months and twelv...

 PRESS RELEASE

Venus Concept Inc. Announces $22.25 Million Equity Financing

Venus Concept Inc. Announces $22.25 Million Equity Financing TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible preferred stock and warrants to purchase common stock in a private placement to a group of investors, including EW Healthcare Partners, HealthQuest Capital and SEDCO Capital. The private placement is expected to result in gross proceeds to the Compa...

 PRESS RELEASE

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial...

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 30, 2020 TORONTO, March 10, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30. Management will host a conference call at 5:00 p.m. Eastern Time on March 30 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may di...

 PRESS RELEASE

Venus Concept Expands Executive Team

Venus Concept Expands Executive Team Chad A. Zaring, Appointed Chief Commercial Officer TORONTO, March 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A. Zaring to the newly-created role of Chief Commercial Officer (“CCO”), effective February 10, 2020. Mr. Zaring has extensive experience in building and executing commercial strategies and driving sales for leading surgical robotics companies in his career. “We ar...

 PRESS RELEASE

Venus Concept Inc. Announces New Regulatory Clearances

Venus Concept Inc. Announces New Regulatory Clearances CE Mark Approval for Venus Bliss™️ for Non-Invasive Lipolysis of Abdomen & Flanks, Skin Tightening, Circumferential Reduction and Cellulite ReductionHealth Canada License to Market NeoGraft 2.0 for hair restoration TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE Mark approval to market Venus Bliss for non-invasive lipolysis of the abdomen and flanks, skin tightening, circumferential re...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch